Agarwal, N., Brugarolas, J., Ghatalia, P., George, S., Haanen, J., Gurney, H., Ravilla, R., Veldt, A. A. M. V. D., Beuselinck, B., Pokataev, I., Suelmann, B. B., Tuthill, M. H., Vaena, D. A., Zhang, Y., Chuang, C., Vajdi, A., Loboda, A., Perini, R. F., Merchan, J. R., Atkins, M. B. (2026). Biomarker analysis from the phase 2 LITESPARK-013 study of 2 different belzutifan (bel) doses in participants (pts) with advanced clear cell renal cell carcinoma (ccRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.545